Conversely, the reduction in CD206 and CD163 expression combined with increased NLRP3 expression and ROS production in macrophages treated with CM from LpOC01-SN-cured CRC cells suggests a shift toward a pro-inflammatory macrophage state (Figure 4). Here, CD163 is linked to colorectal carcinoma.